{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T07:07:09Z","timestamp":1785654429509,"version":"3.56.0"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":6855,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1994,6]]},"abstract":"<jats:p>The vestibular, cerebellar, and reticular systems are central in importance, in motion sickness and habituation, to the effects of motion. Nuclear medicine single photon emission computed tomography (SPECT) studies of cerebral blood flow and power spectral electroencephalographic recordings during motion sickness were used to determine alterations in the central nervous system. The rotating chair with and without visual stimulation was used to study the rate of habituation and the effect of antimotion sickness medications on this rate. An increase of theta waves over the frontal cortex indicated a decreased activation of the higher centers during motion sickness. Motion sickness also produces an increase of blood flow in the central cerebellum that has connections to the reticular system. This increase in cerebellar activity is relayed to the reticular system whereby neural recruitment builds up to trigger the vomiting center, producing motion sickness. Habituation may be a conditioned compensatory activation of the reticular neurons that prevents this disruption of normal activation. The rate of habituation when motion sickness was prevented by scopolamine was slowed, indicating that, if the central nervous system is not challenged by disruption of normal activation, it does not produce the compensatory reactions that result in habituation.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1994.tb02016.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T19:30:42Z","timestamp":1362771042000},"page":"628-634","source":"Crossref","is-referenced-by-count":41,"title":["Habituation and Motion Sickness"],"prefix":"10.1002","volume":"34","author":[{"given":"Charles D.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Struve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Straumanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm E.","family":"Mims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Y.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"157","article-title":"Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness","volume":"61","author":"Wood CD","year":"1990","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_3_2","first-page":"1112","article-title":"Nuclear medicine evaluation of motion sickness and medications on gastric emptying time","volume":"58","author":"Wood MJ","year":"1987","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_4_2","first-page":"453","article-title":"Diagnostic criteria for grading the severity of acute motion sickness","volume":"39","author":"Graybiel A","year":"1968","journal-title":"Aerospace Med"},{"key":"e_1_2_1_5_2","first-page":"867","article-title":"Evaluation of a new antinauseant drug for prevention of motion sickness","volume":"48","author":"Graybiel A","year":"1977","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016486809126317"},{"key":"e_1_2_1_7_2","first-page":"527","article-title":"Visually\u2010induced sickness in normal and bilaterally labyrinthine\u2010defective subjects","volume":"62","author":"Cheung BSK","year":"1991","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_8_2","first-page":"650","article-title":"Susceptibility to acute motion sickness in blind persons","volume":"41","author":"Graybiel A","year":"1970","journal-title":"Aerospace Med"},{"key":"e_1_2_1_9_2","first-page":"1071","article-title":"Human performance during two weeks in a room rotating at three RPM","volume":"35","author":"Guedry FE","year":"1964","journal-title":"Aerospace Med"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1152\/jappl.1962.17.3.398","article-title":"Compensatory nystagmus conditioned during adaptation to living in a rotating room","volume":"17","author":"Guedry FE","year":"1962","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_11_2","first-page":"539","article-title":"The effect of antimotion sickness drugs on habituation to motion","volume":"57","author":"Wood CD","year":"1986","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1949.29.4.311"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)91040-0"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1967.00760050357023"},{"key":"e_1_2_1_15_2","first-page":"462","article-title":"Electroencephalographic spectral changes during motion sickness","volume":"62","author":"Chelen WE","year":"1991","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1950.00230180015002"},{"key":"e_1_2_1_17_2","article-title":"Sopite syndrome: a sometimes sole manifestation of motion sickness","author":"Graybiel A","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_1_18_2","first-page":"249","article-title":"Theory of antimotion sickness drug mechanisms","volume":"43","author":"Wood CD","year":"1972","journal-title":"Aerospace Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1970115621"},{"key":"e_1_2_1_20_2","first-page":"461","article-title":"The effect of motion sickness on brain waves (EEG)","volume":"61","author":"Wood MJ","year":"1991","journal-title":"Aviat Space Environ Med"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1994.tb02016.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1994.tb02016.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T03:00:36Z","timestamp":1698116436000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1994.tb02016.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1994,6]]}},"alternative-id":["10.1002\/j.1552-4604.1994.tb02016.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1994.tb02016.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,6]]}}}